Change of hs-CRP,sVCAM-1,NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifudipine

Objective:To investigate the change of the hs-CRP,sVC AM-1,NT-proBNP levels of the patients with pregnancy-induced hypertension(PIH) syndrome.Methods:A total of 200 patients with PIH were divided into mild,moderate and severe group,and 50 healthy pregnancy patients served as the control group.The serum sVCAM-1 levels were detected by enzyme-linked immunosorbent assay,hs-CRP were detected by immunity transmission turbidity,and NT-proBNP levels were determined by the colloidal gold method.Patients were treated with magnesium sulfate and nifudipine and the contrastive analysis was performed before and after treatment.And the pathological changes in placental of PIH patients were delected by hematoxylin-eosin staining at the same time.Results:The hs-CRP,sVCAM-l,NT-proBNP levels of patients in the mild, moderate and severe PHI group were significantly higher than that in the control group(P<0.05). The hs-CKP,sVCAM-l,NT-proBNP levels in the severe group were significantly higher than the mild group and the moderate group,the difference was statistically significant(P<0.05).The hsCRP,sVCAM-l,NT-proBNP of the moderate group were significantly higher than the mild group(P<0.05).There was a positive correlation between hs-CRP,sVCAM-1,NT-proBNP expression levels and the degree of the PIH.The expression of hs-CRP,sVCAM-1,NT-proBNP levels of the moderate and the severe group were significantly decreased(P<0.05).The number of placental villi and interstitial blood vessel in the moderate and severe PIH group were significantly less than the control group(P<0.05).Conclusions:The increased levels of serum hs-CRP,sVCAM-1, NT-proBNP may be involved in the process of vascular endothelial cell injury of the PIH,and the hs-CRP,sVCAM-1,NT-proBNP can be used as the auxiliary index for diagnosis of PIH and determination of PIH severity.

Increased Oxidative Stress in Women With Pregnancy-induced Hypertension

Objective To investigate whether pregnancy-induced hypertension （PIH） may increase oxidative stress in women with PIH, and to explore the mechanisms by which PIH may increase oxidative stress and potential free radical damage. Methods Seventy women with PIH and seventy women with uncomplicated normotensive pregnancy （UNP） whose age, nutritional conditions, levels of hemoglobin and albumin were all matched, were enrolled in a randomized controlled trial. Their plasma concentrations of nitric oxide （NO）, vitamin C （VC）, vitamin E （VE）, and β-carotene （β-CAR） as well as their erythrocyte malondialdehyde （MDA）, and activities of superoxide dismutase （SOD）, catalase （CAT） and glutathione peroxidase （GPX） were determined by spcctrophotometry. Results Compared with average values of the above experimental parameters in the women with UNP, the average value of erythrocyte MDA in the women with PIH significantly increased （P〈0.0001）, while the average values of plasma NO, VC, VE, and β-CAR as well as those of erythrocyte SOD, CAT, and GPX in the women with PIH significantly decreased （P〈0.0005-0.0001）. The findings from partial correlation analysis （controlling for age） for 70 women with PIH showed that with elevated systolic blood pressure （SBP） and diastolic blood pressure （DBP）, MDA value gradually increased （P〈0.001）, and NO, VC, VE, β-CAR, SOD, CAT, and GPX values gradually decreased （P〈0.02-0.001）. The findings from reliability analysis for NO, VC, VE, β-CAR, SOD, CAT, GPX, and MDA values used to reflect increased oxidative stress and potential free radical damage in women with PIH showed that the reliability coefficients （alpha, 8 items） = 0.7062, P〈 0.0001, and the standardized item alpha = 0.9116, P〈 0.0001. Conclusion The findings in the present research suggest that pregnancy-induced hypertension can increase oxidative stress and potential free radical damage in women with pregnancy-induced hypertension.

Expression of TGF-β1 in Placenta of the Patients with Pregnancy-induced Hypertension and Its relationship with Serum VCAM-1

The expression of transforming growth factor-β1 (TGF-β1) in placental tissue of pregnancy-induced hypertension (PIH) and the relationship between the level of expression of TGF-β1 and the amount of vascular cell adhesion molecule-1 (VCAM-1) in serum was studied. Immunohistochemistry ABC was used to detect the expression and distribution of TGF-β1 in placental tissues in 40 PIH women and 20 normal pregnancy women. High resolution pathological image analysis system was used to determine the quality of TGF-β1. The VCAM-1 in serum was examined by enzyme linked immunoabsorbent assay (ELISA). The results showed that TGF-β1 could be express in syncytiotrophoblast. The levels of TGF-β1 expression in placental tissues of the patients with moderate and severe PIH were significantly higher (P<0.05), while the serum VCAM-1 was significantly lower than in normal group (P<0.01). There was a significant positive correlation between the expression of TGF-β1 in placental tissues and the serum VCAM-1 (r=0.969, P<0.01). It was concluded that the level of TGF-β1 expression in PIH was increased and was positively correlated with the amount of serum VCAM-1, indicating that they might be involved in the pathogenesis of PIH.

A Cross-Sectional Study on Current Practice of the Management of Pregnancy Induced Hypertension and Its Maternal and Foetal Complications and Outcome in the Western Part of the State of Libya

Background: Maternal and perinatal mortality and morbidity are mainly affected by hypertension during pregnancy (pre-eclampsia). Haemorrhage and cerebral bleeding are the primary and significant complications of pre-eclampsia. Abruption of the placenta and renal failure are among the major complications caused by this disease. The perinatal complications include Intrauterine Growth Restriction (IUGR), Intrauterine Foetal Death (IUFD), neonatal death, and prematurity. Objective: The purpose of the present study was to examine the incidence of Pregnancy-Induced Hypertension (PIH), pre-eclampsia, the management of PIH, including the early diagnosis, the pharmacological drug management used, and the prevalence of maternal and perinatal complications. Methods and Patients: This cross-sectional study took place in Aljalaa maternity hospital, which represented the west of the state of Libya in the period from 1st January 2012 to 31st December 2012, with patients who were diagnosed, managed, and terminated according to protocol management of the hospital. Results: In the present study, from the total deliveries in Aljalaa Maternity hospital, the incidence of PIH is 8.4% and pre-eclampsia is 5.1%. No maternal mortality, CNS haemorrhaged, hepatic failure, or renal failure. The reported maternal complications included: Eclampsia, HELLP syndrome (Haemolysis, Elevated Liver enzymes and Low platelets), abruption placenta, and pulmonary oedema see in eighteen percent, six percent, nine percent, four percent and less than one percent, respectively. The foetal complications were preterm babies and Intrauterine Growth Restriction (IUGR) in nineteen percent, Low Birth Weight (LBW) in twenty-five percent, Intrauterine Foetal Death (IUFD) in five percent, neonatal death in two percent and, perinatal death in six percent. In the PIH patients, the presence of associated symptoms such as headache, blurred vision, irritability, and the presence of signs such as severe hypertension, generalized oedema, exaggerated reflexes, and abnormal investigations (protein urea, high uric acid, abnormal LFT, haemoconcentration, and low pits) increased the risk of maternal and foetal complications. Conclusion: To decrease mother and newborn mortality and morbidity in PIH patients, a rigorous management protocol is required to implement evidence-based guidelines.

The Expression of PLF in Placenta in Pregnancy-Induced Hypertension and the Relationship between the PLF and Serum VCAM-1

To study the expression of placental isoferritin (PLF) in placental tissue of pregnancy-induced hypertension (PIH) and the relationship between the level of expression of PLF and the amount of vascular cell adhesion molecule-1 (VCAM-1) in serum, immunohistochemical technique was used to detect the expression of PLF in placenta tissue in 45 PIH patients (PIH group) and 15 normal pregnant women (normal group). High resolution pathological image analysis system (HPIAS-100) was employed to determine the quantity of PLF. The VCAM-1 in serum was examined by enzyme linked immunoabsorbent assay (ELISA). The results showed that the levels of PLF expressions in moderate and severe PIH patients were significantly lower than that of normal group (P<0. 01). The serum VCAM-1 was significantly decreased in PIH group (1310±177 ρ/ng/ml) than that of normal group (609±72 ρ/ng/ml, P<0. 01). The significant negative correlation existed between the expression of PLF in placental tissue and the serum VACM-1 (r=-0. 58, P<0. 01). It was concluded that the level of PLF expression in PIH decreases and is negatively correlated with the amount of serum VCAM-1, indicating that these may be involved in the pathogenesis of PIH.

The Activity of Plasma Platelet-activating Factor Derived from Pregnant Women before and after Delivery and lts Relation to Pregnancy-induced Hypertension

The activity of plasma platelet-activating factor(PAF) from pregnant women before and after delivery was determined. Plasma samples were taken from 74 pregnant women, among whom 24 were normotensive controls, 30 mild and moderate hypertensive and 20 severe hypertensive. Of the two hypertensive groups(pregnancy-induced hypertension, PIH), PAF activity measured by a bioassay was significantly higher than that of normotensive control at 38 weeks in gestation , indicating a possible role of this potent lipid mediator in the pathophysiological mechanism of PIH. After delivery, PAF activity was obviously increased in all three groups , showing the regulation of placenta in PAF metabolism.

Effects of IGF-Ⅱand TGF-β1 on invasiveness of placental trophoblast cells in patients with pregnancy-induced hypertension syndrome

Objective: This study was to investigate the invasiveness of pregnancy-induced hypertension (PIH) trophoblast cells and evaluate the effects of IGF-Ⅱand TGF-β1 on cytotrophoblast invasion.Methods: Cytotrophoblast cells from normal and PIH placenta were separated and purified. Cytotrophoblast invasiveness of normal and PIH placenta was measured by in vitro invasion assay. Effects of IGF-Ⅱand TGF-β1 on cytotrophoblast invasion were also studied.Results: In PIH group, cytotrophoblast invasiveness was dramatically decreased. In normal group, trophoblast invasiveness was significantly enhanced by IGF-Ⅱ but inhibited by TGF-β1. Neither IGF-Ⅱ nor TGF-β1 had statistically significant effects on PIH trophoblast invasion.Conclusions: PIH cytotrophoblast invasiveness dramatically decreases as compared to the normal level. IGF-Ⅱand TGF-β1 may play an important role in shallow trophoblast invasion on PIH.

Fundus changes in pregnancy induced hypertension

AIM: To determine the prevalence of retinal changes in pregnancy induced hypertension (PIH) and any association between the retinal changes and blood pressure, proteinuria, and severity of the disease. METHODS: All the patients admitted with diagnosis of PIH were included in this study. Age, race, gravida, gestation period, blood pressure, and proteinuria were noted from the case records. After taking history for any eye symptoms, fundus examination was done after dilating the pupils with direct ophthalmoscope in the ward itself. All the findings were noted on a data sheet, and were analyzed using SPSS programme. RESULTS: A total of 78 patients of PIH were examined. Majority (75.6%) were Malays. The mean age of patients was 30.2 years (range 21-45 years). The gestation period ranged from 25 weeks to 41 weeks; 34 (43.5%) were primi gravida. Thirty (38.4%) patients had mild preeclampsia, 46 (59%) had severe preeclampsia and 2(2.5%) had eclampsia. Retinal changes (hypertensive retinopathy) were noted in 46 (59%) patients --- grade I in 41 (52.6%) and grade II in 5 (6.4%). Haemorrhages or exudates or retinal detachment were not seen in any patient. There was statistically significant positive association of retinal changes and blood pressure (P =0.001), proteinuria (P =0.018) and severity of the PIH (P =0.024). CONCLUSION: Retinal changes (grade I and II hypertensive retinopathy) were seen in 59% of patients with PIH and they were significantly associated with blood pressure, proteinuria and severity of the disease. Fundus examination helps in assessing the severity of PIH.

Expression of Endothelial Nitric Oxide Synthase Traffic Inducer in the Placenta of Pregnancy Induced Hypertension

The expression of endothelial nitric oxide synthase traffic inducer （NOSTRIN） in the placenta of the patients with pregnancy induced hypertension （PIH） was detected and its role in the pathogenesis of PIH was studied. The pathological changes in placental vessels were observed by HE staining. NO2-/NO3- , the stable metabolic end products of NO, was measured with nitrate reductase. The eNOS activity in placental tissues was assayed by spectrophotometry. Western blot analysis was applied to detect NOSTRIN expression. The incidence of thickening and fibronoid necrosis of placental vessels was significantly higher in women with PIH than in the normal group （P〈 0.01）. The levels of placental NO2-/NO3- in PIH patients （27. 53±7.48 μmol/mg） were significantly lower than in normal group （54. 27±9.53 μmol/mg, P〈0.01）. The activity of eNOS was significantly decreased in PIH group （12. 826±3.61 U/mg） as compared with that in normal group （21. 72±3.83 U/mg, P〈0.01）. Western blot analysis revealed that both groups expressed 58 kD NOSTRIN, but the protein level was significantly higher in women with PIH than in the normal group （P〈0.01）. A significant negative correlation existed between the expression of NOSTRIN protein and the activity of eNOS in placental tissue of women with PIH （r=-0.57, P〈0.01）. It was concluded that the level of NOSTRIN expression in placenta of women with PIH was increased, which may play an important role in the pathogenesis of PIH.

Changes of plasma nitric oxide in patients with pregnancy induced hypertension

Objective: To explore the role of nitric oxide (NO), an internal vasodilative factor, in occurrence ofpregnancy induced hypertension (PIH). Methods: The antepartum and postpartum levels of NO2-/NO3-, the stable metabolic end product of NO, and those of cyclic guanosine monophosphate (cGMP) in 30 patients with PIHand 30 healthy women in their late pregnancy were measured with greiss reagent. ResultS: ① The plasma levels ofNO2-/NO3- and cGMP were significantly decreased in patients with PIH as compared with the healthy women (P<0. 05). ②In patients with PlH, the antepartum level of NO2-/NO3- was markedly lower than the postpartum one(P<O. ol ). ③There was a negative correlation between the level of plasma NO2- /NO3- and systolic blood pressurein patients with PIH (P<0. 01). ④ A positive correlation was found between the level of plasma NO2-/NO3- andthat of cGMP in patients with PIH (P<0. 01). Conclusion: The decrease of NO synthesis may play an importantrole in occurrence of PIH.

Immunohistochemical Analysis of Globulin and Complements in Blood Vessels of Placental Villi during Pregnancy Induced Hypertension

The changes of globulin and complements in placental villi blood vessels were immunohistochemically studied in pregnancy induced hypertension patients and normal pregnant patients by a randomized , double-blind approach. The immunostaining of IgG, IgE, C3, C4, and 5-HT was seen in the villous blood vessels and the helicine arteries of pregnancy induced hypertensive placental villi.The strong positive rates were 100%, 90%, 100%, 100% and 90% in seriouspregnancy induced hypertensive patients, accompanied by aggregation of mastocytes and vasculopathy of villous blood vessels and the helicine arteries. It is concluded that the immuno-pathological damage took place in the villous blood vessels and helicine arteries, resulting in vasculopathy and villous regressive changesand that the immunological factors were closely related to pregnancy induced hypertension.

The decrease of serum vascular endothelial growth factor concentration in patients with pregnancy induced hypertension

Objectives:To detect the concentration of serum vascular endothelial growth factor (VEGF) in patients with pregnancy induced hypertension (PIH) as well as to explore the role of VEGF in the pathogenesis of Pffl.Methods: Serum VEGF concentrations in 23 healthy nonpregnant women (normal group) ,30 normal pregnant women (control group) and 37 women with PIH (PIH group) were measured by sandwich enzyme- linked immunoadsorbent assay (ELISA). Results: Serum concentrations of VEGF in control group were significantly higher (149.39 + 27.15ng/L) than those in normal group (11.98 + 3.99ng/L) ( P < 0.001) , peaking in the second trimester of pregnancy (183.84 + 49.02ng/L) and decreasing in the third trimester (118.37 + 34.29ng/L) . Serum VEGF concentrations (64.45 + 24.33ng/L) in PIH group were significantly lower than those in normal late pregnancy women of control group (118.37 + 34.29ng/L) ( P < 0.01) . There was a trend that serum VEGF concentrations in PIH group decreased with the severity of Pffl (P < 0.05) . Conclusion: The serum VEGF concentration in PIH women are significantly decreased, which suggests that VEGF may play an important role in the pathogenic mechanism of PIH.

Study of the Prevalence of Hypertension and Complications of Hypertensive Disorders in Pregnancy

Introduction: Hypertension is one of the common problems associated with pregnancy that may be followed by eclampsia, acute renal failure, maternal death, premature delivery, intra-uterine growth restriction and other. This study was conducted to determine the results of pregnancies associated with hypertension in patients visiting in the Delivery Ward of Valiasr Hospital. Methods: A descriptive study was conducted on all the patients admitted to the aforementioned department and who possessed the inclusion criteria for hypertensive pregnancy. Results: Among the 1694 delivery cases examined, 173 cases had hypertension (9.8%). Among these, 75 (45%) had gesta-tional hypertension;24 (14.8%) had preeclampsia-eclampsia;30 (18%) had preeclampsia su-perimposed on chronic hypertension;21 (13.5%) cases had chronic hypertension;and 13 (8%) had pregnancy-aggravated chronic hypertension. Ninety-six point three percent (96.3%) had a systolic blood pressure (BP) of 140 - 190 mmHg, and 3.7% had a systolic BP greater than 190 mmHg. Whereas 61.1% of diastolic blood pressure 90 - 110 mmHg and 38.9% of the mothers had diastolic BP greater than 110 mmHg. The HELLP (Hemolysis, Elevated Liver enzymes & Low Platelet count) syndrome was present in 4.9% of cases;52.6% experienced premature delivery;7.4% had IUFD (intra uterine fetal death);9.9% had IUGR (intrauterine growth retardation);and 17.3% had LBW babies. Conclusions: Based on our results, hypertensive mothers who are younger and have lower weight babies at birth experience more perinatal complications. The unpleasant effects of hypertension in pregnancy warrant the need for training, routine prenatal care, the early detection and treatment of hypertension at younger ages of pregnancy, and follow-up after delivery.

超声E-cervix弹性成像参数与妊娠期高血压孕晚期分娩方式的关系

目的分析超声E-cervix弹性成像参数与妊娠期高血压孕晚期分娩方式的关系。方法纳入进行产检的孕晚期妊娠期高血压孕产妇100例,所有孕产妇均实施超声E-cervix弹性成像参数检查,所有孕产妇均随访至最终分娩,统计所有孕产妇的分娩方式并依据分娩方式分为2组(自然分娩及剖宫产),分析超声超声E-cervix弹性成像参数对妊娠期高血压孕晚期分娩方式选择的影响。结果经随访统计,100例妊娠期高血压孕晚期孕产妇自然分娩共63例,占比63.00%;剖宫产共37例,占37.00%;自然分娩组弹性对比指数(elasticity contrast index,ECI)、宫颈外口应变(external os strain,EOS)值均大于剖宫产组,硬度比值(hardness ratio,HR)、宫颈长度(cervical length,CL)、宫颈内口应变(internal os strain,IOS)、宫颈内外口应变比值(IOS/EOS)值小于剖宫产组,差异有统计学意义(P<0.05);经点二列相关性证实,超声E-cervix弹性成像参数与妊娠期高血压孕晚期分娩方式间的关系呈正相关(P<0.05)。结论超声E-cervix弹性成像参数可评价宫颈组织变化情况,或可作为评价宫颈成熟度的半定量指标,对妊娠期高血压孕晚期分娩方式的选择具有一定的指导意义。

临床-生化评价脂溶性抗氧化剂治疗妊娠高血压疾病的有效性

目的探讨临床-生化评价脂溶性抗氧化剂治疗妊娠高血压疾病的有效性。方法选取2021年1月—2022年7月广东省东莞市黄江医院收治的100例妊娠期高血压疾病患者为对象。通过随机抽签法将患者分为2组,每组50例。对照组采用常规综合疗法,观察组联用维生素E治疗。比较2组患者的疾病指标、凝血功能指标、氧化应激指标。结果治疗前,2组患者疾病指标比较,差异无统计学意义(P>0.05);治疗1周后,2组患者舒张压、收缩压、24 h尿蛋白定量均低于治疗前,且观察组舒张压、收缩压、24 h尿蛋白定量分别为(82.11±4.58)mmHg、(131.42±6.42)mmHg、(0.17±0.04)g,低于对照组的(88.79±4.73)mmHg、(139.72±6.74)mmHg、(0.26±0.06)g,差异有统计学意义(P<0.05)。治疗前,2组患者凝血功能指标比较,差异无统计学意义(P>0.05);治疗1周后,2组患者凝血酶原时间(prothrombin time,PT)、凝血酶时间(thrombin time,TT)、活化部分凝血活酶时间(activated partial thromboplastin time,APTT)、纤维蛋白原(fibrinogen,FIB)优于治疗前,且观察组PT、TT、APTT、FIB优于对照组,差异有统计学意义(P<0.05)。治疗前,2组患者氧化应激指标比较,差异无统计学意义(P>0.05);治疗1周后,2组患者丙二醛(malonaldehyde,MDA)、缺血修饰白蛋白(ischemia modified albumin,IMA)、髓过氧化物酶(myeloperoxidase,MPO)均低于治疗前,且观察组MDA、IMA、MPO低于对照组,差异有统计学意义(P<0.05)。结论脂溶性抗氧化剂可在妊娠高血压疾病治疗中发挥较好的效果,通过临床-生化评价可辅助临床及时明确患者的疾病转归情况,有利于临床更好地运用药物治疗疾病。

黄精多糖对妊娠期高血压模型大鼠胎盘组织TGF-β/Smad信号通路的作用研究

[目的]探讨黄精多糖对妊娠期高血压模型大鼠胎盘功能的影响与机制。[方法]受孕雌性大鼠随机分为对照组、模型组、黄精多糖(低、中、高)剂量组(100、200、400 mg/kg)和硫酸镁组(100 mg/kg),每组10只。除对照组外,其余组大鼠皮下注射L-精氨酸甲酯构建妊娠期高血压模型。检测血压、24 h蛋白尿、胎鼠体质量、胎盘质量;苏木素-伊红(HE)检测胎盘组织病理学;酶联免疫吸附实验(ELISA)检测胎盘组织白介素(IL)-6、IL-10、肿瘤坏死因子-α(TNF-α)含量;Western Blot检测胎盘组织紧密连接蛋白-1(ZO-1)、封闭蛋白(OCLN)、血管内皮生长因子(VEGF)、转化生长因子-β1(TGF-β1)、p-Smad3、Smad3蛋白表达。[结果]与对照组比较,模型组大鼠血压、24 h尿蛋白、IL-6、TNF-α含量及TGF-β1、p-Smad3蛋白表达显著升高,胎鼠体质量、胎盘质量、IL-10含量及ZO-1、OCLN、VEGF蛋白表达显著降低(P<0.05),且胎盘组织出现病理学损伤。与模型组比较,各给药组大鼠血压、24 h尿蛋白、IL-6、TNF-α含量及TGF-β1、p-Smad3蛋白表达显著降低,胎鼠体质量、胎盘质量、IL-10含量及ZO-1、OCLN、VEGF蛋白表达显著升高(P<0.05),同时胎盘组织病理学损伤减轻。[结论]黄精多糖可抑制妊娠期高血压模型大鼠胎盘中TGF-β/Smad信号通路激活,改善胎盘功能障碍。

Effect of Salvia Miltiorrhiza Injection on Blood Pressure and Cardiac Function in Rats with Gestational Hypertension and Preeclampsia

Objective: This study is to observe the effects of Salvia miltiorrhiza injection on blood pressure and cardiac function in rats with pregnancy-induced hypertension and preeclampsia. Methodology: Syncytiotrophoblast microvilli (stbm) and l-arginine nitrosyl methyl ester were screened out via caudal vein injection. Twenty gestational hypertension-preeclampsia model SD (Sprague Dawley) rats successfully induced by L-NAME (L-arginine Nitrosyl methyl ester) were randomly divided into 2 groups (model group and Danshen injection group, n = 10). Then another 10 normal pregnant SD rats without model were selected as blank control group. The Salvia miltiorrhiza injection group was given Salvia miltiorrhiza injection (0.5 g?kg?1?d?1) through tail vein, and the control group and model group were given equal volume of normal saline through tail vein injection. All three groups were treated by tail vein injection once a day (d) for 7 days. After treatment, heart rate (HR), Systolic pressure (SP), diastolic pressure (DP) and mean arterial pressure (MAP) were measured by tail artery. Left ventricular end-diastolic diameter (LVDd) and Left ventricular end systolic diameter (LVDs) were recorded by echocardiography. Left ventricular end diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP), left ventricular ejection fraction (left ventricular ejection) fraction, LVEF) and the maximum rate of increase/decrease of left ventricular pressure during isovolemic systole (+dp/dtmax/?dp/dtmax);Endothelin-1 (ET-1) levels in rat tail vein blood were detected by ELISA. Results: SP, DP, MP, HR, LVSP, LVDs and ?dp/dtmaxx were all decreased, plasma ET-1 expression was low, and LVDd, LVEDP, LVEF, and +dp/dtmax were all increased in the Salvia miltiorroot injection group, with statistical significance compared to the model group (p Conclusion: Salvia miltiorrhiza injection can improve the cardiac function and reduce blood pressure in rats with pregnancy-induced hypertension and preeclampsia, and the mechanism may be related to alleviating systemic arteriolar spasm by regulating ET-1 level.

D-二聚体与凝血指标在妊娠期高血压疾病孕妇中的临床检验价值

目的 探讨D-二聚体与凝血指标在妊娠期高血压疾病孕妇中的临床检验价值。方法 选取80例妊娠期高血压疾病孕妇为试验组,同期来院检查的80例正常孕妇为对照组,所有孕妇均进行D-二聚体与凝血指标检验,分析其临床检验价值。结果 试验组孕妇凝血酶原时间、活化部分凝血活酶时间、凝血酶时间短于对照组(P<0.05),纤维蛋白原、D-二聚体水平高于对照组(P<0.05);随着妊娠期高血压疾病孕妇病情的不断加重,凝血酶原时间、活化部分凝血活酶时间、凝血酶时间逐渐缩短,纤维蛋白原、D-二聚体水平逐渐升高,差异具有统计学意义(P<0.05);D-二聚体联合凝血指标的诊断价值高于单项检验(AUC>0.9)。结论 D-二聚体与凝血指标检验可以辅助临床判断孕妇妊娠期高血压疾病的严重程度,且联合检验的诊断价值高于单项检验。

妊娠期高血压患者血清ficolin-3、Angptl4水平变化及其临床意义

目的:探讨妊娠期高血压患者血清纤维蛋白胶凝素-3(ficolin-3)、血管生成素样蛋白4(Angptl4)水平变化及其临床意义。方法:选取2020年5月至2022年5月在本院接受治疗的102例妊娠期高血压患者作为观察组,根据患者病情,分为高血压组(37例)、轻度子痫前期组(42例)和重度子痫前期组(23例);另选取同一期间102名孕检健康孕妇作为对照组。采用酶联免疫吸附法(ELISA)测定血清ficolin-3、Angptl4水平。采用Pearson相关系数分析血清ficolin-3与Angptl4的相关性;采用受试者工作特征(ROC)曲线检测血清ficolin-3、Angptl4对妊娠期高血压的诊断价值;采用Logistic回归分析妊娠期高血压发生的危险因素。结果:与对照组比较,观察组血清ficolin-3、Angptl4水平均明显降低(P<0.05)。高血压组、轻度子痫前期组、重度子痫前期组血清ficolin-3、Angptl4水平逐步降低(P<0.05)。观察组患者血清ficolin-3与Angptl4呈正相关(r=0.527,P<0.001)。血清ficolin-3、Angptl4联合诊断妊娠期高血压的ROC曲线下面积(AUC)大于单独诊断的AUC(Z=2.595,P=0.009;Z=5.201,P<0.001)。与对照组比较,观察组血小板计数(PLT)明显降低,血小板平均体积(MPV)、血小板分布宽度(PDW)、血小板聚集率(PagT)明显升高(P<0.05)。血清ficolin-3低表达、Angptl4低表达、PLT低水平、MPV高水平、PDW高水平、PagT高水平是妊娠期高血压发生的危险因素(P<0.05)。结论:妊娠期高血压患者血清ficolin-3、Angptl4水平均降低,且与妊娠期高血压病情严重程度相关,检测两者水平变化可对妊娠期高血压进行准确评价。